Industry News
Biotechnology Industry News
Genentech, Novome team up to study seaweed-controlled oral cell therapies in IBD
Genentech, Novome team up to study seaweed-controlled oral cell therapies in IBD ntaylor Thu, 11/11/2021 - 07:51
After snapping up Parexel with Goldman Sachs, EQT doubles down on healthcare with Life Sciences Partners buyout
After snapping up Parexel with Goldman Sachs, EQT doubles down on healthcare with Life Sciences Partners buyout badams Wed, 11/10/2021 - 08:20
Immatics’ cell therapy blasts solid tumors in phase 1, but durability spooks investors. Will dialing up the dose help?
Immatics' cell therapy blasts solid tumors in phase 1, but durability spooks investors. Will dialing up the dose help? ntaylor Wed, 11/10/2021 - 08:06
Startup Regulonix pursues non-opioid pain drug that indirectly blocks a key ion channel
Startup Regulonix pursues non-opioid pain drug that indirectly blocks a key ion channel aliu Wed, 11/10/2021 - 07:41
Psilocybin clears biggest depression test yet, but Compass stock falls amid chatter about adverse events, durability
Psilocybin clears biggest depression test yet, but Compass stock falls amid chatter about adverse events, durability ntaylor Wed, 11/10/2021 - 05:30
Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf
Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf badams Wed, 11/10/2021 - 04:37
Novartis dumps 2nd bispecific from $2.6B Xencor pact, dealing further blow to hopes for blood cancer target
Novartis dumps 2nd bispecific from $2.6B Xencor pact, dealing further blow to hopes for blood cancer target ntaylor Tue, 11/09/2021 - 08:08
Seeking an edge over Amgen, Mirati advances lower KRAS dose in Keytruda combo to improve tolerability
Seeking an edge over Amgen, Mirati advances lower KRAS dose in Keytruda combo to improve tolerability ntaylor Tue, 11/09/2021 - 06:54
Once-failed cancer drug from BioXcel ramps up immunotherapy in mouse models of pancreatic cancer
Once-failed cancer drug from BioXcel ramps up immunotherapy in mouse models of pancreatic cancer arlene.weintraub Mon, 11/08/2021 - 09:33
Gyroscope spins the wheel again as it taps Sanofi for $60M months after ditching IPO attempt
Gyroscope spins the wheel again as it taps Sanofi for $60M months after ditching IPO attempt badams Mon, 11/08/2021 - 09:00
GSK pulls off clean sweep of endpoint hits in anemia phase 3, positioning it to leapfrog AstraZeneca
GSK pulls off clean sweep of endpoint hits in anemia phase 3, positioning it to leapfrog AstraZeneca ntaylor Mon, 11/08/2021 - 06:27
Blackstone bets on Autolus’ CD19 CAR-T in $250M deal, clearing path to pivotal readout in 2022
Blackstone bets on Autolus' CD19 CAR-T in $250M deal, clearing path to pivotal readout in 2022 ntaylor Mon, 11/08/2021 - 05:26
Provention Bio, hit by AdComm rejection for lead drug, hires early research exec from Gossamer
Provention Bio, hit by AdComm rejection for lead drug, hires early research exec from Gossamer badams Mon, 11/08/2021 - 04:13
Provention Bio, hit by rejection for lead drug, hires early research exec from Gossamer
Provention Bio, hit by rejection for lead drug, hires early research exec from Gossamer badams Mon, 11/08/2021 - 04:13
Treating drug-resistant prostate cancer by exploiting tumor-suppressing RNA
Treating drug-resistant prostate cancer by exploiting tumor-suppressing RNA arlene.weintraub Fri, 11/05/2021 - 08:11
UPDATE: Pfizer’s oral COVID-19 antiviral cuts hospitalization, death by 85%, sending team barreling to FDA
UPDATE: Pfizer's oral COVID-19 antiviral cuts hospitalization, death by 85%, sending team barreling to FDA ntaylor Fri, 11/05/2021 - 07:41
UPDATE: Pfizer’s oral COVID-19 antiviral cuts hospitalization, death by 89%, sending team barreling to FDA
UPDATE: Pfizer's oral COVID-19 antiviral cuts hospitalization, death by 89%, sending team barreling to FDA ntaylor Fri, 11/05/2021 - 07:41
HitGen taps Cambridge Molecular for ‘deep learning’ drug discovery collab
HitGen taps Cambridge Molecular for 'deep learning' drug discovery collab badams Fri, 11/05/2021 - 07:22
Moderna scraps lead mRNA chikungunya candidate after phase 1, slowing push beyond prophylactic vaccines
Moderna scraps lead mRNA chikungunya candidate after phase 1, slowing push beyond prophylactic vaccines ntaylor Fri, 11/05/2021 - 06:50
Parkinson’s gene therapy restores responses to dopamine-boosting drug in mouse models
Parkinson's gene therapy restores responses to dopamine-boosting drug in mouse models klahucik Thu, 11/04/2021 - 17:52